Given its central role in the pathogenesis of PC, NF-κB presents itself as a key therapeutic target, with potential for the development of new strategies based on natural molecules that regulate this signaling and favor tumor cell apoptosis, particularly in advanced PC [13,14,15]. This evidence concerns the gene NFKB1 and pachyonychia congenita.